Add Company
Join Now

Nuo Therapeutics Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Nuo Therapeutics's estimated annual revenue is currently $3.7M per year.(i)
  • Nuo Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Nuo Therapeutics has 24 Employees.(i)
  • Nuo Therapeutics grew their employee count by 4% last year.

Nuo Therapeutics's People

NameTitleEmail/Phone
1
EA to CEOReveal Email/Phone
2
CEO & Chief Financial OfficerReveal Email/Phone
3
VP SalesReveal Email/Phone
4
Regional Sales Director - WestReveal Email/Phone
5
Regional Sales Director ~WestReveal Email/Phone
6
Customer Service ManagerReveal Email/Phone
7
CSO/COOReveal Email/Phone
8
Marketing ConsultantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.3M2-60%N/AN/A
#2
$2.9M38-31%$17.5MN/A
#3
$2.9M38-33%$10.5MN/A
#4
$19.8M1280%$69.4MN/A
#5
$9.6M62-15%N/AN/A
#6
$1.4M90%N/AN/A
#7
$2.5M160%N/AN/A
#8
$7.4M480%N/AN/A
#9
$0.2M1-83%N/AN/A
#10
$1.7M1122%N/AN/A
Add Company

What Is Nuo Therapeutics?

Nuo Therapeutics, Inc. (formerly Cytomedix, Inc.) is a biomedical company that develops and commercializes individualized wound care therapies that harness a patient’s innate regenerative ability to stimulate wound healing. The Company’s flagship product, Aurix is a biodynamic hematogel derived from the patient’s own platelets and plasma, which is used at the point-of-care to jumpstart the natural healing process in a broad range of chronic wounds, including diabetic foot ulcers, venous leg ulcers and pressure ulcers (bedsores).

keywords:N/A

N/A

Total Funding

24

Number of Employees

$3.7M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.5M24-40%N/A
#2
$2.5M25-4%N/A
#3
$7.5M25-37%N/A
#4
$2.5M259%N/A
#5
$1.8M25-17%N/A